Skip to main content
TipRanks
Go Ultimate75% OFF

Louise Rodino-Klapac Insider Profile

11 Followers

Louise Rodino-Klapac, President, R&D and Tech Ops at Sarepta Therapeutics, holds 203.90K shares in Sarepta Therapeutics (Ticker: SRPT).

Louise Rodino-Klapac's Trading History

SRPT
Sarepta Therapeutics
Sep 08, 2026President, R&D and Tech OpsUninformative Sell476.02K$3.01M
SRPT
Insider Shares: 203.90K (0.19%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 08, 2026Uninformative Sell$476.02K21,423$22.22―
Mar 13, 2026Uninformative Sell$16.14K948$17.03―
Mar 11, 2026Uninformative Sell$23.71K1,399$16.95―
Mar 03, 2026Uninformative Buy$61.01K3,640$16.76―
Nov 19, 2025Uninformative Sell$84.40K4,582$18.42―

You May Also Like

Louise Rodino-Klapac insider profile FAQ

What stocks does Louise Rodino-Klapac hold?
Louise Rodino-Klapac holds: SRPT stocks.
What was Louise Rodino-Klapac’s latest transaction?
Louise Rodino-Klapac’s latest transaction was an Uninformative Sell of $476.02K.
What is Louise Rodino-Klapac's role in Sarepta Therapeutics?
Louise Rodino-Klapac's role in Sarepta Therapeutics is President, R&D and Tech Ops.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.